Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of ENVB will rise by +9.27% over the next 2 Weeks and hit $1.99 by Friday, May 1, 2026. In that time frame, ENVB's share price is expected to range between $1.87 and $2.12.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| May 1, 2026 | 1.70 | 1.83 | 1.95 |
| Apr 30, 2026 | 1.82 | 1.93 | 2.05 |
| Apr 29, 2026 | 1.77 | 1.89 | 2.01 |
| Apr 28, 2026 | 1.70 | 1.82 | 1.94 |
| Apr 27, 2026 | 1.68 | 1.81 | 1.92 |
| Apr 24, 2026 | 1.71 | 1.82 | 1.94 |
| Apr 23, 2026 | 1.80 | 1.92 | 2.05 |
| Apr 22, 2026 | 1.77 | 1.89 | 2.01 |
| Apr 21, 2026 | 1.69 | 1.81 | 1.93 |
| Apr 20, 2026 | 1.69 | 1.80 | 1.93 |
ENVB shares rose +134.89% in Monday, April 20, 2026's trading session, rising from a previous close of $1.82 to move at $4.28. The stock demonstrated notable intraday movement (see ENVB's key stats for a full breakdown), fluctuating between $4.05 and $5.43, a +34.06% trading range. While recent weeks have seen some volatility, ENVB has managed to secure a +110.59% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 1.14M shares changing hands, 9.8M fewer than the previous session. This amounted to $4.85M in total market activity.
Will ENVB Continue Its Downward Trend?
According to analyst ratings and projections for ENVB, Enveric Biosciences, Inc. shares are anticipated to decrease by -119.73%, potentially reaching $1.95 per share by May 1, 2026. Short-term technical indicators currently suggest a neutral sentiment for ENVB. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 12 positive trading days within the past 30 sessions. Based on the ENVB stock forecast, now is not the best time to buy ENVB stock because its current trading price is +134.02% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on ENVB covering social and institutional perspectives.
ENVB Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into ENVB's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 71.60% to 81.50%) indicate the stock is in a strong bullish momentum phase. The 50-day RSI, at 51.72%, suggests a neutral medium-term outlook. However, the 100-day RSI, at 44.03%, maintains a neutral outlook for the long term. Insights into ENVB's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Enveric Biosciences Short-Term Forecasts
ENVB Forecast For Next 5 Days
Our algorithm anticipates Enveric Biosciences (ENVB) stock could hit $2.01 by Apr 27, 2026. This represents a -53.01% rise from today's price, following a +5.76% change over the past five days.
ENVB Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Enveric Biosciences, Inc. (ENVB) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $1.56, which would mean a -63.51% decrease from the current price of $4.28. Projections for this period range from a high of $2.59 to a low of $0.69.
ENVB Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Enveric Biosciences's price over the next three months point to a drop. ENVB stock is expected to peak at $12.47 on Jun 01, 2026 before potentially dipping to $0.00 on Jul 20, 2026. On average, ENVB is likely to trade around $1.27 in the coming 90 days.
Enveric Biosciences Stock Forecast 2025
Based on our predictive models, Enveric Biosciences (ENVB) is expected to trade between $0.00 and $12.47 throughout 2026. This would result in an average price of $0.91, potentially offering investors a -78.71% return from current levels.
Enveric Biosciences, Inc. Monthly Forecast 2026–2027
April 2026
According to our latest forecast models, Enveric Biosciences, Inc. (ENVB) is positioned to show a strong performance in April 2026. The price is predicted to move between $0.00 and $9.93, settling at an average of $1.23. This could translate to a -71.23% loss.
May 2026
Based on current market signals, Enveric Biosciences, Inc. is projected to trend may 2026. We forecast a trading range from $0.00 to $11.84, with a likely average price of $1.53. Investors could expect a potential return of -64.21%.
June 2026
Our predictive algorithms indicate Enveric Biosciences, Inc. stock may see a shift in June 2026. The expected range spans $0.00–$12.47, with an average target of $1.32. This represents a cautious outlook and a possible loss of -69.12%.
July 2026
Analyzing established trends, Enveric Biosciences, Inc. looks set to move in July 2026. Projections place the stock between $0.00 and $10.36, averaging around $0.88. This suggests a -79.42% loss from current levels.
August 2026
Market indicators suggest Enveric Biosciences, Inc. could experience notable changes during August 2026. Prices could fluctuate within $0.00 to $10.53, with a midpoint forecast of $1.04. The stock might deliver a -75.67% loss.
September 2026
Forecasting for September 2026, models estimate that Enveric Biosciences, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $10.53, averaging $0.90. This signals a cautious trajectory with potential returns around -78.95%.
October 2026
According to our latest forecast models, Enveric Biosciences, Inc. (ENVB) is positioned to show a strong performance in October 2026. The price is predicted to move between $0.00 and $10.66, settling at an average of $0.80. This could translate to a -81.29% loss.
November 2026
Based on current market signals, Enveric Biosciences, Inc. is projected to trend november 2026. We forecast a trading range from $0.00 to $10.16, with a likely average price of $0.41. Investors could expect a potential return of -90.41%.
December 2026
Our predictive algorithms indicate Enveric Biosciences, Inc. stock may see a shift in December 2026. The expected range spans $0.00–$10.56, with an average target of $0.34. This represents a cautious outlook and a possible loss of -92.05%.
January 2027
Analyzing established trends, Enveric Biosciences, Inc. looks set to move in January 2027. Projections place the stock between $0.00 and $9.94, averaging around $0.30. This suggests a -92.98% loss from current levels.
February 2027
Market indicators suggest Enveric Biosciences, Inc. could experience notable changes during February 2027. Prices could fluctuate within $0.00 to $10.07, with a midpoint forecast of $0.18. The stock might deliver a -95.79% loss.
March 2027
Forecasting for March 2027, models estimate that Enveric Biosciences, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $9.56, averaging $0.17. This signals a cautious trajectory with potential returns around -96.02%.
April 2027
According to our latest forecast models, Enveric Biosciences, Inc. (ENVB) is positioned to show a strong performance in April 2027. The price is predicted to move between $0.00 and $9.24, settling at an average of $0.07. This could translate to a -98.36% loss.
ENVB's history of dividends and stock splits also plays a role in long-term investor confidence.

